Narrative review highlights potential of transition metal complexes with antibiotics for osteomyelitis, implying a shift in infection treatment strategies.
Severe fractures, tumors, and bone surgery are risk factors for bone infection. Infected bone defects are chronic conditions in which the ability of local tissue and bone to regenerate is severely compromised. One type of infection, osteomyelitis, is a common orthopedic condition caused by pathogenic microorganisms. Infections have led to challenging complications such as fracture nonunion and delayed bone healing. Moreover, the emergence of bacterial resistance to conventional antibiotics is making advanced antibacterial agents an urgent goal, as the benefits of traditional antibiotics are gradually diminishing. This review summarizes advances in regenerative bone medicine, biomaterials, and implant technologies. From the perspective of antibacterial strategies, it also discusses future challenges and prospects for infection control with a focus on metalloantibiotics in bone-related applications.
No takes yet. Share an insight, caveat, or question.
Scolari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: